NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
UNITED STATES |
OMB APPROVAL |
OMB Number: |
3235-0080 |
Expires: |
March 31, 2018 |
Estimated average burden |
hours per response: |
1.7 |
|
|
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM 25 |
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
Commission File Number |
001-33650 |
|
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
|
Address: |
420 LEXINGTON AVENUE |
|
SUITE 450 |
|
NEW YORk |
NEW YORK |
10170 |
Telephone number: |
| 212-584-4171 |
|
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
Class A Common Stock Purchase Warrants |
(Description of class of securities)
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
|
Pursuant to the requirements fo the Securities Exchange Act of 1934,
NYSE MKT LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
2012-07-16 |
By |
Edwin Mecabe |
|
Managing Director |
Date |
|
Name |
Title |
|
1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
|
NOTIFICATION OF THE REMOVAL FROM LISTING
AND REGISTRATION OF THE STATED SECURITIES
The null hereby notifies the SEC of its
intention to remove the entire class of
the stated securities from listing and
registration on the Exchange at the opening
of business on July 27, 2012, pursuant to
the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on
July 16, 2012 the instruments representing
the securities comprising the entire class
of this security came to evidence, by
operation of law or otherwise, other securities
in substitution therefore and represent
no other right except, if such be the fact,
the right to receive an immediate cash payment.
Pursuant to the terms of the Warrants
Agreement the Warrants (Expiring July 16,
2012) of NeoStem, Inc. expired on July 16,
2012. Each Warrant entitled the holder to
purchase one (1) share of Common Stock of
NeoStem, Inc. at an exercise price of $6.00
per share.
The Exchange also notifies the Securities
and Exchange Commission that as a result of
the above indicated conditions this security
was suspended from trading on July 11, 2012.